# A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome

A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome | Cellular & Molecular Immunology

===============

Your privacy, your choice
-------------------------

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media, as well as to allow video information to be shared for both marketing, analytics and editorial purposes.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our [privacy policy](https://www.nature.com/info/privacy) for more information on the use of your personal data.

Manage preferences for further information and to change your choices.

Accept all cookies Reject optional cookies

[Skip to main content](https://doi.org/10.1038/s41423-020-0372-4#content)

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

[![Image 3: Cellular & Molecular Immunology](https://media.springernature.com/full/nature-cms/uploads/product/cmi/header-dc5a5fd94cc61b958f99b334d381a6e1.svg)](https://doi.org/cmi)

*   [View all journals](https://www.nature.com/siteindex)
*   [Search](javascript:;)

Search
------

Search articles by subject, keyword or author  Show results from  Search   [Advanced search](https://doi.org/search/advanced) 
### Quick links

    *   [Explore articles by subject](https://doi.org/subjects)
    *   [Find a job](https://doi.org/naturecareers)
    *   [Guide to authors](https://doi.org/authors/index.html)
    *   [Editorial policies](https://doi.org/authors/editorial_policies/)

*   [Log in](https://idp.nature.com/auth/personal/springernature?redirect_uri=https://www.nature.com/articles/s41423-020-0372-4)

*   [Content Explore content](javascript:;)

Explore content
---------------

    *   [Research articles](https://doi.org/cmi/research-articles)
    *   [Reviews & Analysis](https://doi.org/cmi/reviews-and-analysis)
    *   [News & Comment](https://doi.org/cmi/news-and-comment)
    *   [Current issue](https://doi.org/cmi/current-issue)
    *   [Collections](https://doi.org/cmi/collections)

    *   [Sign up for alerts](https://journal-alerts.springernature.com/subscribe?journal_id=41423)
    *   [RSS feed](https://www.nature.com/cmi.rss)

*   [About the journal](javascript:;)

About the journal
-----------------

    *   [Aims & Scope](https://doi.org/cmi/aims)
    *   [Journal Information](https://doi.org/cmi/journal-information)
    *   [Open Access Fees and Funding](https://doi.org/cmi/open-access)
    *   [About the Editors](https://doi.org/cmi/editors)
    *   [About the Partner](https://doi.org/cmi/partner)
    *   [Editorial Board](https://doi.org/cmi/editorial-board)
    *   [Contact](https://doi.org/cmi/contact)
    *   [For Advertisers](https://doi.org/cmi/advertising)
    *   [Subscribe](https://doi.org/cmi/subscribe)

*   [Publish with us](javascript:;)

Publish with us
---------------

    *   [For Authors & Referees](https://doi.org/cmi/authors-and-referees)
    *   [Language editing services](https://authorservices.springernature.com/go/sn/?utm_source=For+Authors&utm_medium=Website_Nature&utm_campaign=Platform+Experimentation+2022&utm_id=PE2022)
    *   [Open access funding](https://doi.org/cmi/open-access-funding)
    *   [Submit manuscript](https://mts-cmi.nature.com/cgi-bin/main.plex)

*   [Sign up for alerts](https://journal-alerts.springernature.com/subscribe?journal_id=41423)
*   [RSS feed](https://www.nature.com/cmi.rss)

1.   [nature](https://doi.org/)
2.   [cellular & molecular immunology](https://doi.org/cmi)
3.   [comment](https://doi.org/cmi/articles?type=comment)
4.   article

 A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome 

[Download PDF](https://doi.org/articles/s41423-020-0372-4.pdf)

[Download PDF](https://doi.org/articles/s41423-020-0372-4.pdf)

*   Comment
*   Published: 05 February 2020

A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome
=================================================================================

*   [Shibo Jiang](https://doi.org/10.1038/s41423-020-0372-4#auth-Shibo-Jiang-Aff1)[1](https://doi.org/10.1038/s41423-020-0372-4#Aff1), 
*   [Shuai Xia](https://doi.org/10.1038/s41423-020-0372-4#auth-Shuai-Xia-Aff1)[1](https://doi.org/10.1038/s41423-020-0372-4#Aff1), 
*   [Tianlei Ying](https://doi.org/10.1038/s41423-020-0372-4#auth-Tianlei-Ying-Aff1)[ORCID: orcid.org/0000-0002-9597-2843](https://orcid.org/0000-0002-9597-2843)[1](https://doi.org/10.1038/s41423-020-0372-4#Aff1)&
*   …
*   [Lu Lu](https://doi.org/10.1038/s41423-020-0372-4#auth-Lu-Lu-Aff1)[1](https://doi.org/10.1038/s41423-020-0372-4#Aff1)

Show authors
[_Cellular & Molecular Immunology_](https://doi.org/cmi)**volume 17**,page 554 (2020)[Cite this article](https://doi.org/10.1038/s41423-020-0372-4#citeas)

*   13k Accesses

*   167 Citations

*   25 Altmetric

*   [Metrics details](https://doi.org/articles/s41423-020-0372-4/metrics)

By the end of 2019, the World Health Organization (WHO) was informed about an outbreak of pneumonia of unknown etiology in Wuhan, China. Some patients were linked to a seafood market, suggesting animal-to-human transmission, but, soon, human-to-human transmission was confirmed. The pathogen was promptly identified as a novel coronavirus belonging to lineage B betacoronaviruses that also include severe acute respiratory syndrome coronavirus (SARS-CoV), which caused a pandemic in China in 2002/2003, and bat SARS-like coronaviruses.[1](https://doi.org/articles/s41423-020-0372-4#ref-CR1 "Jiang, S., Du, L. & Shi Z. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerg. Microbes Infect. 9, 275–277 (2020).")

Since 2012, the outbreak of Middle East respiratory syndrome coronavirus infection starting from Saudi Arabia has resulted in 2494 confirmed cases and 858 deaths in 27 countries, posing ongoing threat to global public health ([https://www.who.int/emergencies/mers-cov/en](https://www.who.int/emergencies/mers-cov/en)).

As of 1 February 2020, there were 12,024 confirmed cases with Wuhan pneumonia and 259 deaths, of which 11,860 cases were found in Mainland China and 164 in 26 other countries and territories. The estimated case fatality rate is about 2%, which is much lower than that of SARS (9.6%), while its transmission rate (R0) is 2–3% ([https://www.worldometers.info/coronavirus](https://www.worldometers.info/coronavirus)), similar to that of SARS (3%). Like SARS-CoV-infected individuals, patients infected with this novel betacoronavirus showed abnormal findings on chest computed tomography, along with common symptoms that include fever, cough, and myalgia, or fatigue, at the onset of illness. Still, all indications suggest that the acute respiratory syndrome of SARS is, so far, more severe than that manifested by the present pneumonia outbreak.[2](https://doi.org/articles/s41423-020-0372-4#ref-CR2 "Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 
                  https://doi.org/10.1016/S0140-6736(20)30183-5
                  
                 (2020).")

The novel coronavirus was denoted as “2019-nCoV” by WHO ([https://www.who.int/emergencies/diseases/novel-coronavirus-2019](https://www.who.int/emergencies/diseases/novel-coronavirus-2019)) and the Wuhan pneumonia was named as “novel coronavirus-infected pneumonia (NCIP)” by Chinese scientists.[3](https://doi.org/articles/s41423-020-0372-4#ref-CR3 "Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 
                  https://doi.org/10.1056/NEJMoa2001316
                  
                 (2020).") However, it will seem illogical if coronavirus is listed after NCIP, i.e., “novel coronavirus-infected pneumonia coronavirus (NCIP-CoV)”. Therefore, we suggest renaming NCIP as “pneumonia-associated respiratory syndrome (PARS)” and 2019-nCoV as “PARS coronavirus (PARS-CoV)”, similar to SARS-CoV, to _retain equivalent terminology_.

References
----------

1.   Jiang, S., Du, L. & Shi Z. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. _Emerg. Microbes Infect_. **9**, 275–277 (2020).

2.   Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. _Lancet_. [https://doi.org/10.1016/S0140-6736(20)30183-5](https://doi.org/10.1016/S0140-6736(20)30183-5) (2020).

3.   Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. _N. Engl. J. Med_. [https://doi.org/10.1056/NEJMoa2001316](https://doi.org/10.1056/NEJMoa2001316) (2020).

[Download references](https://citation-needed.springer.com/v2/references/10.1038/s41423-020-0372-4?format=refman&flavour=references)

Author information
------------------

### Authors and Affiliations

1.   School of Basic Medical Sciences, Fudan University, 131 Dong An Road, Fuxing Building, Xuhui District, Shanghai, 200032, China

Shibo Jiang,Shuai Xia,Tianlei Ying&Lu Lu

Authors
1.   Shibo Jiang[View author publications](https://doi.org/search?author=Shibo%20Jiang) Search author on:[PubMed](https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shibo%20Jiang)[Google Scholar](https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shibo%20Jiang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en)  
2.   Shuai Xia[View author publications](https://doi.org/search?author=Shuai%20Xia) Search author on:[PubMed](https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shuai%20Xia)[Google Scholar](https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shuai%20Xia%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en)  
3.   Tianlei Ying[View author publications](https://doi.org/search?author=Tianlei%20Ying) Search author on:[PubMed](https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tianlei%20Ying)[Google Scholar](https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tianlei%20Ying%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en)  
4.   Lu Lu[View author publications](https://doi.org/search?author=Lu%20Lu) Search author on:[PubMed](https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lu%20Lu)[Google Scholar](https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lu%20Lu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en)  

### Corresponding author

Correspondence to [Shibo Jiang](mailto:shibojiang@fudan.edu.cn).

Ethics declarations
-------------------

### Competing interests

The authors declare no competing interests.

Rights and permissions
----------------------

[Reprints and permissions](https://s100.copyright.com/AppDispatchServlet?title=A%20novel%20coronavirus%20%282019-nCoV%29%20causing%20pneumonia-associated%20respiratory%20syndrome&author=Shibo%20Jiang%20et%20al&contentID=10.1038%2Fs41423-020-0372-4&copyright=CSI%20and%20USTC&publication=1672-7681&publicationDate=2020-02-05&publisherName=SpringerNature&orderBeanReset=true)

About this article
------------------

[![Image 4: Check for updates. Verify currency and authenticity via CrossMark](blob:http://localhost/df43c82f6cb6dcd2a87db38f317bf9f2)](https://crossmark.crossref.org/dialog/?doi=10.1038/s41423-020-0372-4)

### Cite this article

Jiang, S., Xia, S., Ying, T. _et al._ A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome. _Cell Mol Immunol_**17**, 554 (2020). https://doi.org/10.1038/s41423-020-0372-4

[Download citation](https://citation-needed.springer.com/v2/references/10.1038/s41423-020-0372-4?format=refman&flavour=citation)

*   Received: 01 February 2020

*   Accepted: 01 February 2020

*   Published: 05 February 2020

*   Version of record: 05 February 2020

*   Issue date: May 2020

*   DOI: https://doi.org/10.1038/s41423-020-0372-4

### Share this article

Anyone you share the following link with will be able to read this content:

Get shareable link

Sorry, a shareable link is not currently available for this article.

Copy shareable link to clipboard

Provided by the Springer Nature SharedIt content-sharing initiative

### Subjects

*   [Target identification](https://doi.org/subjects/target-identification)
*   [Viral infection](https://doi.org/subjects/viral-infection)

This article is cited by
------------------------

*   ### [The role of TIGIT-CD226-PVR axis in mediating T cell exhaustion and apoptosis in NSCLC](https://doi.org/10.1007/s10495-024-02052-2)

    *   Liang Qian
    *   Ling Wu
    *   Yao Zhou

_Apoptosis_ (2025)

*   ### [Pathogenic mechanisms of cardiovascular damage in COVID-19](https://doi.org/10.1186/s10020-024-00855-2)

    *   Hong-Hua Shao
    *   Rui-Xing Yin

_Molecular Medicine_ (2024)

*   ### [Association between diet history and symptoms of individuals having recovered from COVID-19](https://doi.org/10.1186/s41043-023-00365-7)

    *   Ola T. Sahloul
    *   Talaat M. Sahloul

_Journal of Health, Population and Nutrition_ (2023)

*   ### [Bioactive molecules from plants: a prospective approach to combat SARS-CoV-2](https://doi.org/10.1007/s13596-021-00599-y)

    *   Gagan Kumar Panigrahi
    *   Shraban Kumar Sahoo
    *   Kunja Bihari Satapathy

_Advances in Traditional Medicine_ (2023)

*   ### [Socio-demographic Heterogeneity in Prevalence of SARS-COV-2 Infection and Death Rate: Relevance to Black College Student Knowledge of COVID-19 and SARS-COV-2](https://doi.org/10.1007/s40615-021-01193-3)

    *   Jahangir Emrani
    *   Elia Nichelle Hefner

_Journal of Racial and Ethnic Health Disparities_ (2023)

[Download PDF](https://doi.org/articles/s41423-020-0372-4.pdf)

*   Sections
*   References

*   [References](https://doi.org/10.1038/s41423-020-0372-4#Bib1)
*   [Author information](https://doi.org/10.1038/s41423-020-0372-4#author-information)
*   [Ethics declarations](https://doi.org/10.1038/s41423-020-0372-4#ethics)
*   [Rights and permissions](https://doi.org/10.1038/s41423-020-0372-4#rightslink)
*   [About this article](https://doi.org/10.1038/s41423-020-0372-4#article-info)
*   [This article is cited by](https://doi.org/10.1038/s41423-020-0372-4#further-reading)

1.   Jiang, S., Du, L. & Shi Z. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. _Emerg. Microbes Infect_. **9**, 275–277 (2020).

2.   Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. _Lancet_. [https://doi.org/10.1016/S0140-6736(20)30183-5](https://doi.org/10.1016/S0140-6736(20)30183-5) (2020).

3.   Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. _N. Engl. J. Med_. [https://doi.org/10.1056/NEJMoa2001316](https://doi.org/10.1056/NEJMoa2001316) (2020).

Cellular & Molecular Immunology  (_Cell Mol Immunol_)

ISSN 2042-0226 (online)

ISSN 1672-7681 (print)

nature.com sitemap
------------------

### About Nature Portfolio

*   [About us](https://www.nature.com/npg_/company_info/index.html)
*   [Press releases](https://www.nature.com/npg_/press_room/press_releases.html)
*   [Press office](https://press.nature.com/)
*   [Contact us](https://support.nature.com/support/home)

### Discover content

*   [Journals A-Z](https://www.nature.com/siteindex)
*   [Articles by subject](https://www.nature.com/subjects)
*   [protocols.io](https://www.protocols.io/)
*   [Nature Index](https://www.natureindex.com/)

### Publishing policies

*   [Nature portfolio policies](https://www.nature.com/authors/editorial_policies)
*   [Open access](https://www.nature.com/nature-research/open-access)

### Author & Researcher services

*   [Reprints & permissions](https://www.nature.com/reprints)
*   [Research data](https://www.springernature.com/gp/authors/research-data)
*   [Language editing](https://authorservices.springernature.com/language-editing/)
*   [Scientific editing](https://authorservices.springernature.com/scientific-editing/)
*   [Nature Masterclasses](https://masterclasses.nature.com/)
*   [Research Solutions](https://solutions.springernature.com/)

### Libraries & institutions

*   [Librarian service & tools](https://www.springernature.com/gp/librarians/tools-services)
*   [Librarian portal](https://www.springernature.com/gp/librarians/manage-your-account/librarianportal)
*   [Open research](https://www.nature.com/openresearch/about-open-access/information-for-institutions)
*   [Recommend to library](https://www.springernature.com/gp/librarians/recommend-to-your-library)

### Advertising & partnerships

*   [Advertising](https://partnerships.nature.com/product/digital-advertising/)
*   [Partnerships & Services](https://partnerships.nature.com/)
*   [Media kits](https://partnerships.nature.com/media-kits/)
*   [Branded content](https://partnerships.nature.com/product/branded-content-native-advertising/)

### Professional development

*   [Nature Awards](https://www.nature.com/immersive/natureawards/index.html)
*   [Nature Careers](https://www.nature.com/naturecareers/)
*   [Nature Conferences](https://conferences.nature.com/)

### Regional websites

*   [Nature Africa](https://www.nature.com/natafrica)
*   [Nature China](http://www.naturechina.com/)
*   [Nature India](https://www.nature.com/nindia)
*   [Nature Japan](https://www.natureasia.com/ja-jp)
*   [Nature Middle East](https://www.nature.com/nmiddleeast)

*   [Privacy Policy](https://www.nature.com/info/privacy)
*   [Use of cookies](https://www.nature.com/info/cookies)
*   Your privacy choices/Manage cookies 
*   [Legal notice](https://www.nature.com/info/legal-notice)
*   [Accessibility statement](https://www.nature.com/info/accessibility-statement)
*   [Terms & Conditions](https://www.nature.com/info/terms-and-conditions)
*   [Your US state privacy rights](https://www.springernature.com/ccpa)

[![Image 5: Springer Nature](https://doi.org/static/images/logos/sn-logo-white-ea63208b81.svg)](https://www.springernature.com/)
© 2025 Springer Nature Limited
